---
title: "Treace Medical Concepts, Inc. (TMCI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TMCI.US.md"
symbol: "TMCI.US"
name: "Treace Medical Concepts, Inc."
industry: "Health Care Equipment"
datetime: "2026-06-13T20:40:34.566Z"
locales:
  - [en](https://longbridge.com/en/quote/TMCI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TMCI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TMCI.US.md)
---

# Treace Medical Concepts, Inc. (TMCI.US)

## Company Overview

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.treace.com](https://www.treace.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-13T04:30:12.000Z

**Overall: C (0.57)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 77 / 184 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.66% |  |
| Net Profit YoY | -15.20% |  |
| P/B Ratio | 3.41 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 263024810.16 |  |
| Revenue | 207318000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -66.88% | E |
| Profit Margin | -29.44% | E |
| Gross Margin | 79.26% | A |
| Revenue YoY | -1.66% | D |
| Net Profit YoY | -15.20% | D |
| Total Assets YoY | -10.56% | E |
| Net Assets YoY | -26.72% | E |
| Cash Flow Margin | 21.18% | D |
| OCF YoY | -1.66% | D |
| Turnover | 1.06 | A |
| Gearing Ratio | 58.07% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Treace Medical Concepts, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.66%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-15.20%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.41",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "263024810.16",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "207318000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-66.88%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-29.44%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "79.26%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.66%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-15.20%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-10.56%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-26.72%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "21.18%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-1.66%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "1.06",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "58.07%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.31 | 111/184 | - | - | - |
| PB | 3.41 | 81/184 | 4.11 | 2.24 | 1.44 |
| PS (TTM) | 1.27 | 33/184 | 1.87 | 0.87 | 0.59 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 20% |
| Hold | 3 | 60% |
| Underweight | 1 | 20% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.06 |
| Highest Target | 7.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TMCI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TMCI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TMCI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TMCI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**